Juno Diagnostics

Visit Company

Juno Dx is building in-home testing using simple non-invasive devices to provide insights into women's and family health. Juno Diagnostics was born from a group of people that transformed clinical medicine.  The founding team worked together at Sequenom, Inc. (NASDAQ: SQNM), where they pioneered the first noninvasive cell-free DNA based prenatal test in the United States.  Since 2011, these noninvasive prenatal tests have helped millions of families along their pregnancy journey.  Other accomplishments include development of leading genetic testing tools and applications in epigenetics, inherited diseases, and cancer diagnostics.

Dirk van den Boom, Co-Founder and CEO of Juno Diagnostics, talks about molecular diagnostics and Juno Dx’s market strategy.

Mathias Ehrich, Co-Founder and CMO of Juno Diagnostics, talks about his medical background and the Juno Diagnostics testing platform.

Company News:

March 1, 2017

CombiMatrix Appoints Molecular Diagnostics Veteran Dirk van den Boom, Ph.D. to its Board of Directors. Read More: